Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis
Publication
, Journal Article
Tan, IB; Tan, P
Published in: Nature Reviews Clinical Oncology
2011
coloprint® is an 18-gene expression signature designed to predict disease relapse in patients with early-stage colorectal cancer (cRc). we discuss the potential impact of coloprint® on clinical practice, and its contribution to our knowledge of cRc molecular heterogeneity. © 2011 Macmillan Publishers Limited. All rights reserved.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Nature Reviews Clinical Oncology
DOI
ISSN
1759-4774
Publication Date
2011
Volume
8
Issue
3
Start / End Page
131 / 133
Related Subject Headings
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Tan, I. B., & Tan, P. (2011). Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology, 8(3), 131–133. https://doi.org/10.1038/nrclinonc.2010.229
Tan, I. B., and P. Tan. “Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis.” Nature Reviews Clinical Oncology 8, no. 3 (2011): 131–33. https://doi.org/10.1038/nrclinonc.2010.229.
Tan IB, Tan P. Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology. 2011;8(3):131–3.
Tan, I. B., and P. Tan. “Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis.” Nature Reviews Clinical Oncology, vol. 8, no. 3, 2011, pp. 131–33. Scival, doi:10.1038/nrclinonc.2010.229.
Tan IB, Tan P. Genetics: An 18-gene signature (ColoPrint®) for colon cancer prognosis. Nature Reviews Clinical Oncology. 2011;8(3):131–133.
Published In
Nature Reviews Clinical Oncology
DOI
ISSN
1759-4774
Publication Date
2011
Volume
8
Issue
3
Start / End Page
131 / 133
Related Subject Headings
- 1112 Oncology and Carcinogenesis